{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:04:21Z","timestamp":1787015061011,"version":"build-2736575974"},"reference-count":26,"publisher":"Wiley","issue":"s439","license":[{"start":{"date-parts":[[2007,1,2]],"date-time":"2007-01-02T00:00:00Z","timestamp":1167696000000},"content-version":"vor","delay-in-days":1523,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p>\n                    <jats:italic>Aims<\/jats:italic>\n                    : Fabry disease results from deficient activity of the lysosomal enzyme \u03b1\u2010galactosidase A. Progressive accumulation of the major substrates leads, in both men and women, to progressive hypertrophic cardiomyopathy. We aimed to evaluate the utility of different electrocardiographic (ECG) parameters for assessing the degree and severity of hypertrophic cardiomyopathy in patients with Fabry disease.\n                    <jats:italic>Methods<\/jats:italic>\n                    : A total of 166 ECGs of 94 hemi\u2010 and heterozygous patients with Fabry disease were analysed and compared with echocardiographic\u2010estimated left ventricular mass (LVM).\n                    <jats:italic>Results<\/jats:italic>\n                    : There was a significant (\n                    <jats:italic>p<\/jats:italic>\n                    &gt; 0.0001) correlation between QRS duration (R\n                    <jats:sup>2<\/jats:sup>\n                    = 0.59), 12\u2010lead amplitude\/duration product (R\n                    <jats:sup>2<\/jats:sup>\n                    = 0.61), Sokolow\u2010Lyon voltage\/duration product (R\n                    <jats:sup>2<\/jats:sup>\n                    = 0.52) and LVM. Analysis of receiver operating characteristics revealed that the 12\u2010lead amplitude\/duration product had the highest sensitivity\u2010specificity relationship (\n                    <jats:italic>p<\/jats:italic>\n                    &gt; 0.01 compared with the Cornell index).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : In general, ECG signs of left ventricular hypertrophy correlated well with LVM as revealed by echocardiography. Of the parameters studied, the 12\u2010lead amplitude\/duration product was the most successful at describing the severity of cardiac involvement in Fabry disease. These data suggest that ECG parameters have potential for use as a simple and cost\u2010effective means of screening for hypertrophic cardiomyopathy in patients with Fabry disease.\n                  <\/jats:p>","DOI":"10.1111\/j.1651-2227.2002.tb03105.x","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T22:05:37Z","timestamp":1281132337000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Electrocardiographic signs of hypertrophy in Fabry disease\u2010associated hypertrophic cardiomyopathy"],"prefix":"10.1111","volume":"91","author":[{"given":"C","family":"Kampmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CM","family":"Wiethoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Whybra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Miebach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,2]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"113","article-title":"Fabry disease: molecular genetics of the inherited nephropathy","volume":"18","author":"Desnick RJ","year":"1989","journal-title":"Adv Nephrol Necker Hosp"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(67)90027-7"},{"issue":"2","key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-2275(20)43219-5","article-title":"Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry's disease) in comparison with hemizygotes","volume":"31","author":"Hozumi I","year":"1990","journal-title":"J Lipid Res"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.105105"},{"issue":"2","key":"e_1_2_1_6_2","first-page":"S147","article-title":"Cardiac Involvement in Anderson\u2010Fabry Disease","volume":"13","author":"Kampmann C","year":"2002","journal-title":"J AmSocNephrol"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.54.5.818"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(77)80064-1"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012626.81324.38"},{"key":"e_1_2_1_11_2","first-page":"134","article-title":"ECG correlates of left ventricular hypertrophy in Fabry disease","volume":"24","author":"Lubanda JC","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90376-X"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/318809"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"issue":"2","key":"e_1_2_1_16_2","first-page":"R5","article-title":"Influence of enzyme replacement therapy (ERT) on Anderson Fabry disease associated hypertrophic infiltrative cardiomyopathy (HIC)","volume":"161","author":"Kampmann C","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"2","key":"e_1_2_1_17_2","first-page":"263","article-title":"New guidelines for prevention, detection, evaluation, and treatment of hypertension:","volume":"113","author":"Sheps SG","year":"1998","journal-title":"Joint National Committee VI Chest"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-999-0044-3"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(49)90562-1"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(82)90494-X"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.6.1072"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.6.667"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/5.6.175S"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.1991.tb01394.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02380-X"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01606034"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102073240607"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2002.tb03105.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2002.tb03105.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T10:58:42Z","timestamp":1695725922000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2002.tb03105.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":26,"journal-issue":{"issue":"s439","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1111\/j.1651-2227.2002.tb03105.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2002.tb03105.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"2007-01-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}